Correlation Between MaxCyte and Neuropace
Can any of the company-specific risk be diversified away by investing in both MaxCyte and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MaxCyte and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MaxCyte and Neuropace, you can compare the effects of market volatilities on MaxCyte and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MaxCyte with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of MaxCyte and Neuropace.
Diversification Opportunities for MaxCyte and Neuropace
Good diversification
The 3 months correlation between MaxCyte and Neuropace is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding MaxCyte and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and MaxCyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MaxCyte are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of MaxCyte i.e., MaxCyte and Neuropace go up and down completely randomly.
Pair Corralation between MaxCyte and Neuropace
Given the investment horizon of 90 days MaxCyte is expected to generate 40.24 times less return on investment than Neuropace. But when comparing it to its historical volatility, MaxCyte is 2.11 times less risky than Neuropace. It trades about 0.02 of its potential returns per unit of risk. Neuropace is currently generating about 0.35 of returns per unit of risk over similar time horizon. If you would invest 638.00 in Neuropace on August 28, 2024 and sell it today you would earn a total of 428.00 from holding Neuropace or generate 67.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
MaxCyte vs. Neuropace
Performance |
| Timeline |
| MaxCyte |
| Neuropace |
MaxCyte and Neuropace Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MaxCyte and Neuropace
The main advantage of trading using opposite MaxCyte and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MaxCyte position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.| MaxCyte vs. Sight Sciences | MaxCyte vs. CVRx Inc | MaxCyte vs. Neuropace | MaxCyte vs. Rapid Micro Biosystems |
| Neuropace vs. Heartbeam | Neuropace vs. EUDA Health Holdings | Neuropace vs. Nutex Health | Neuropace vs. Healthcare Triangle |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |